Life is a gift, I prefer it in CASH.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
GLTY - nice to see the stock getting some positive attention, way overdue IMO. Good upside potential.
Needs better bid support at this point, someone interested in the stock enough to be slapping that ask pretty good on FRTD. Tighten the spread and lets see where this goes !!
OTHM , looks ready !!!!
Nice board !!! I will make sure I stop by often, but only after I wipe my feet before entering !
Evening Gem, FRTD experienced a little fore play today, as investor watched the volume rose along with the PPS. The stock still will need some gentle but firm slaps on the ask in order to sustain the recent rise. Waiting for this to explode !
I'm doing well, hows by you Gem? Staying out of trouble ?
FRTD, I still have high hopes for this one ( and no it is not a grind it , roll it and smoke it stock) , this has plenty of upside as the company finally is under new management and actually has a product to sell with more in the pipe line!!
WGIH - lotto play, churning.. seeing volume, waiting for PPS to break 0.0002.
OTHM on watch...
CGRA, ready willing and able. Time to see this one get busy
FRTD - saw some nice ask hits earlier, the buying has slowed down.
Everyone waiting to see if are old friend the seller sticks his ugly head up, so far so good, we may finally be in a position to move this PPS without being crushed as in the past.
I am feeling good about the stock right now. Time to tell my friends to step up and hit the ask, push this PPS over a penny !!
CGRA - idle time is getting short, she is primed and ready to move. Stake your claim get in while the getting is good.
So this is the place to be !! Marked the board.
Keeping an eye on CGRA..
FRTD - is so close, needs a little love, slow and steady and she will....
GLTA
d-man
FRTD - distinguishing itself. Company has been placed in a tight spot by its former crooked management, but is now being lead by a smart and honest CEO Thomas Parrila. This company has a huge upside, and the risk/reward aspect should be very appealing.
You should take another L@@K at this sleeper. Big things coming.
I can't find one person that I am speaking to that does not have full confidence that this stock when ready will move and move big time to .20 cents or better.
Company is making all the right moves to build shareholder equity and to provide shareholders with fair and equitable playing field.
Transparent !!!
Holding a piece, and saving my pennies to help with the ride up. Waiting for the catalyst !!
Bolly bands tightening, RSI resetting, a lot of peeps made money on CGRA when she made her move last time. Going to have to start thinking about getting off our hands and start taking some of this beauty at the ask, be sure to be on board for the next run, which should be between 18 and 22 cents IMO.
Company has locked down a good size of the float, will move easy !
FRTD - the company's Comprehensive Airway Management Systems is to be marketed to an ever expanding market place !
"The practical uses of capnography in emergency settings are almost limitless, with new uses continually evolving."
Capnography provides a rapid and reliable method to detect life-threatening conditions which can circumvent potentially irreversible patient injury. Capnography has been shown to be more effective than clinical judgement alone.
just chillin....
NX Global - Caveat Emptor ! Next Norman Birmingham & Rick Papaleo scam company to be revised. You will soon see press I am sure , of marketing contracts, entertainment deals, TV- Radio stations being launched. Who knows maybe even green energy fuels and heart healthy crappy vitamins.
These two are thieves , enter at your own risk, better yet don't enter at all. Sit back and wait for the convertibles to hit the market and watch the blood bath that ensues.
The two thief's !! Birmingham and Papaleo -Looks like Norm Birmingham and Rick Papaleo have reloaded and are preparing to fleece more innocent people with their next venture, all they need is $5M dollars (LOL) and they are looking to go public, imagine that. I bet they will have no trouble finding a shell to plop this turd into.
How can these two crooks sleep at night. They have stolen millions from shareholders over the years and they are looking to do it again. BUYERS BEWARE of this POS: http://sungrainsinc.com/FLASHNET%20GLOBAL%20-%20AMERISTREAM%20JV%20BP.pdf
-
Extremely interesting concept, waste plastics to fuel. I see that they have production, but not at the quantity they would like to achieve. I have to look into this more, the SS is manageable:
Shares Outstanding 89,817,547 a/o Nov 07, 2012
Float 64,955,515 a/o Sep 30, 2012
Authorized Shares 150,000,000 a/o Sep 30, 2012
GLTA
CGRA - news out - looks ready - reset complete !!
CGrowth Capital, Inc. Announces the Completion of Its Site Visit to Mining Locations in Washington State with Jason Otteson of Noble Mining, Inc.
SILVERDALE, Wash., Feb. 14, 2013 /PRNewswire via COMTEX/ -- CGrowth Capital, Inc. (Pink Sheets: CGRA) is pleased to announce that officers of the Company, along with Jason Otteson of Noble Mining, Inc., has finished a site visit of the Company's targeted mining properties and ore bodies in Washington State.
The Company recently hosted a visit by Jason Otteson to its mining location and operations in Washington State. The visit was an important step as the two companies, namely CGrowth Capital and Noble Mining Inc., continue to forge a relationship. The visit also completes a major benchmark in the due diligence process and understanding of the Company's operations and revenue potential by Mr. Otteson.
"We were extremely pleased and honored to have Mr. Otteson accompany us to the Eastern Washington mines." stated Bill Wright, CEO of CGrowth Capital, Inc. "Having a person of Mr. Otteson's caliber to provide independent verification and feedback on our operations shows us how committed Mr. Otteson and Noble Mining are to understanding our full potential and the processes employed by CGrowth Capital in developing the Company's entire team."
Jason Otteson, who has been featured on Discovery Channel's hit show Gold Rush for two seasons, is the founder of Noble Mining, Inc. The 3rd Season of Gold Rush continues to air on Fridays on the Discovery Channel. Discovery's Gold Rush is one of the top shows on TV.
Jason Otteson, CEO of Noble Mining, Inc., states "I enjoyed my visit to the mines and the ancillary properties, as well as getting a chance to meet with key operators on site. Seeing first hand where CGrowth Capital is putting its efforts and the asset base is really exciting. I am looking forward to working with the talented team to prove out reserves and begin seeing revenue generated for the Company."
For more information about CGrowth Capital, visit their website: http://www.CGrowthCapital.com
About CGrowth Capital, Inc.:
?"CGrowth Capital, Inc. serves as a holding company for businesses and assets focused on all aspects of mining. The processing of metal ore mining is a multi-billion dollar market opportunity which is capitalized through processing, sales, contracting and licensing of assets. CGrowth Capital's services and solutions are designed to assist land owners with monetizing undervalued assets by bringing commodities such as gold and silver to market. CGrowth Capital will focus on acquiring or "claiming" land assets, while also providing partners and affiliates with management services, capital, contract management and logistical services necessary for the successful execution of mining operations.
Investor Inquiries:Growth Capital, Inc.888-218-2472
About Noble Mining, Inc.:
Noble Mining is a catalyst to the mining industry and helps navigate and explore promising investment opportunities in the precious metals industry. Precious metals are essential tools for wealth preservation. These tools, once held in low regard, have once again taken on a prominent role in planning for diversification. However, just like any tool, without the right understanding and training the opportunity could be dangerous. There are companies selling gold. There are mining companies with traded stocks. There are prospecting companies offering maps and equipment. One thing is missing: A TRUSTED EXPERT. Noble Mining's Jason Otteson is your trusted expert.
Contact Noble Mining, Inc.:info@NobleMining.comhttp://www.NobleMining.com
Safe Harbor
Statements about the Company's future expectations and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby. The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management as well as assumptions made by and information currently available to the Company or its management. When used in this document, the words "anticipate," "estimate," "expect," "intend," "plans," "projects," and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, intended or projected. In each instance, forward-looking information should be considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing and general economic risks and uncertainties. The Company disclaims any obligation to update or revise any forward-looking statements.
SOURCE CGrowth Capital, Inc.
Didn't do your
CGRA - news out - looks ready - reset complete !!
CGrowth Capital, Inc. Announces the Completion of Its Site Visit to Mining Locations in Washington State with Jason Otteson of Noble Mining, Inc.
SILVERDALE, Wash., Feb. 14, 2013 /PRNewswire via COMTEX/ -- CGrowth Capital, Inc. (Pink Sheets: CGRA) is pleased to announce that officers of the Company, along with Jason Otteson of Noble Mining, Inc., has finished a site visit of the Company's targeted mining properties and ore bodies in Washington State.
The Company recently hosted a visit by Jason Otteson to its mining location and operations in Washington State. The visit was an important step as the two companies, namely CGrowth Capital and Noble Mining Inc., continue to forge a relationship. The visit also completes a major benchmark in the due diligence process and understanding of the Company's operations and revenue potential by Mr. Otteson.
"We were extremely pleased and honored to have Mr. Otteson accompany us to the Eastern Washington mines." stated Bill Wright, CEO of CGrowth Capital, Inc. "Having a person of Mr. Otteson's caliber to provide independent verification and feedback on our operations shows us how committed Mr. Otteson and Noble Mining are to understanding our full potential and the processes employed by CGrowth Capital in developing the Company's entire team."
Jason Otteson, who has been featured on Discovery Channel's hit show Gold Rush for two seasons, is the founder of Noble Mining, Inc. The 3rd Season of Gold Rush continues to air on Fridays on the Discovery Channel. Discovery's Gold Rush is one of the top shows on TV.
Jason Otteson, CEO of Noble Mining, Inc., states "I enjoyed my visit to the mines and the ancillary properties, as well as getting a chance to meet with key operators on site. Seeing first hand where CGrowth Capital is putting its efforts and the asset base is really exciting. I am looking forward to working with the talented team to prove out reserves and begin seeing revenue generated for the Company."
For more information about CGrowth Capital, visit their website: http://www.CGrowthCapital.com
About CGrowth Capital, Inc.:
?"CGrowth Capital, Inc. serves as a holding company for businesses and assets focused on all aspects of mining. The processing of metal ore mining is a multi-billion dollar market opportunity which is capitalized through processing, sales, contracting and licensing of assets. CGrowth Capital's services and solutions are designed to assist land owners with monetizing undervalued assets by bringing commodities such as gold and silver to market. CGrowth Capital will focus on acquiring or "claiming" land assets, while also providing partners and affiliates with management services, capital, contract management and logistical services necessary for the successful execution of mining operations.
Investor Inquiries:Growth Capital, Inc.888-218-2472
About Noble Mining, Inc.:
Noble Mining is a catalyst to the mining industry and helps navigate and explore promising investment opportunities in the precious metals industry. Precious metals are essential tools for wealth preservation. These tools, once held in low regard, have once again taken on a prominent role in planning for diversification. However, just like any tool, without the right understanding and training the opportunity could be dangerous. There are companies selling gold. There are mining companies with traded stocks. There are prospecting companies offering maps and equipment. One thing is missing: A TRUSTED EXPERT. Noble Mining's Jason Otteson is your trusted expert.
Contact Noble Mining, Inc.:info@NobleMining.comhttp://www.NobleMining.com
Safe Harbor
Statements about the Company's future expectations and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby. The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management as well as assumptions made by and information currently available to the Company or its management. When used in this document, the words "anticipate," "estimate," "expect," "intend," "plans," "projects," and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, intended or projected. In each instance, forward-looking information should be considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing and general economic risks and uncertainties. The Company disclaims any obligation to update or revise any forward-looking statements.
SOURCE CGrowth Capital, Inc.
I am not a young man any more homey....
I like your intestinal fortitude, no pun intended
Nice to see you here, good luck....
some hidden clues in there as well, just have not been able to unravel them...
maybe our seller is Birmingham and his family and or friend , flushing his way out the door. If so he or anyone else that is selling in this manner is an idiot.
This fits his style, mindless and reckless, not giving a chit about shareholders, only for him or themselves.
Total BS !!!
FRTD - News out -Fortitude Group Inc. Announces the Acquisition of Legacy Life Science (L2S)
ERIE, Pa., Jan 29, 2013 (BUSINESS WIRE) -- Fortitude Group Inc., (Symbol FRTD) CEO Thomas Parilla today introduces its first acquisition to its medical division, Legacy Life Science (L2S).
The L2S premium product portfolio contains the Comprehensive Airway Management System consisting of five, patented FDA approved products ready for worldwide distribution and sales. The Comprehensive Airway Management System is engineered to significantly reduce and prevent respiratory distress in the perioperative procedural sedation environment (anesthesia). A common scenario in peri-operative procedural sedation involves degradation of patient airway monitoring and management; and therefore, constitutes the designation as a Hospital Acquired Condition or (HAC) for respiratory related distress. Current standard of care is insufficient, the result:
-- 1M annual pulmonary complications after surgical procedures in the U.S.
-- 350,000 respiratory arrests annually from complications and over 46,200 deaths
-- 3M added patient days, resulting in 2M added ICU days and over $12 billion
Eighty percent of complications during anesthesia are due to airway mishaps and respiratory distress(i.e., obstruction and/or closure). A recent market designation of capnography as a "standard of care" by the American Society of Anesthesiologists (ASA) and other professional organizations clearly recognize the growing importance to protect patients from respiratory events leading to death, these respiratory events are categorized as HAC(s). The L2S Comprehensive Airway Management System meets the new ASA Standards.
The total annual US market includes the hospital inpatient $1.05 billion dollars and hospital outpatient $855 million dollars. Due to the clinical application of the new American Society of Anesthesiologists (ASA) guidelines, business analysts predict the market will double by 2017 and exceed $4 billion dollars.
Fortitude Group Inc., President Christopher J. Cuzzola commented, "Dr. Colantonio and I are very familiar with this product line. We understand the important role the Comprehensive Airway Management System plays in saving patient lives and improving clinical outcomes while meeting the new ASA Guidelines. "We're very excited about the growth prospects within our Life Science Division, and shareholders can expect additional updates to follow in the very near future"
About:
Fortitude Group Inc. develops practical solutions for healthcare with direct holdings, subsidiaries and or joint ventures. The Company's service-product portfolio includes premium FDA approved medical devices and advanced technologies engineered to prevent the risk associated healthcare acquired conditions and improve clinical outcomes.
Safe Harbor:
This press release contains forward-looking statements. Such forward-looking statements are subject to a number of risks, assumptions and uncertainties that could cause the Company's actual results to differ materially from those projected in such statements. Forward-looking statements speak only as of the date made and are not guarantees of future performance. We undertake no obligation to publicly revise any forward-looking statements./
Contact Sterling Capitol Investor Relations Kent Thomas Phone - (631) 824-7661 Email - IR-FRTD@sterlingcapitol.net
http://cts.businesswire.com/ct/CT?id=bwnews&sty=20130129005699r1&sid=cmtx4&distro=nx
SOURCE: Fortitude Group Inc.
GLDN - 0.0101 x 0.0135 -
Gold Dynamics seeks to identify, acquire, and develop deposits which have the potential to be world class and in an acceptable risk environment.
Social responsibility and environmental stewardship are core values of the Company.
Share Structure
Market Value1- $1,032,500 a/o Jan 25, 2013
Shares Outstanding- 103,250,000 a/o Dec 24, 2012
Looks like pink sheest has been update new O/S number shows reduction !!!
Shares Outstanding 142,014,337 a/o Jan 24, 2013
The Doctor is in the house !! You can't argue about his resume, very impressive, great asset.
FTRD - is there a Doctor in the house , Yes there is NEWS OUT!!
FRTD - news out - Erie, PA., January 28, 2013 – Fortitude Group Inc., Today introduces Anthony J. Colantonio, MD Chief Medical Innovation Officer of the Life Science Division.
Fortitude Group Inc., (Ticker Symbol FRTD) CEO Thomas Parilla is pleased to announce Anthony J. Colantonio, MD accepted the position of Chief Medical Innovation Officer of the Life Science Division.
Dr. Colantonio completed fellowship training in Interventional Pain Medicine at the Oregon Health and Science University, residency training at Duke University in Anesthesiology, and medical and undergraduate education at Georgetown University and is a Diplomat of the American Board of Anesthesiology and the American Academy of Pain Management. Dr. Colantonio is the Director of the Clinic for Specialty Pain Services at Meadville Medical Center, with a clinical focus upon neuromodulation therapy and geriatric care. Dr. Colantonio is a regional key opinion leader for numerous pharmaceutical and medical device companies and a national speaker for Pfizer Pharmaceuticals.
As a clinician-inventor, Colantonio is a tireless advocate for patients and medical providers and has dedicated his entrepreneurial career to identifying critical healthcare problems and solving them with innovative products and services. Anthony holds two utility patents through the USPTO and six patents pending. As the Chief Medical Officer of the Life Science Division, Dr. Colantonio leads the research and development efforts from initial product design to bench-top testing, clinical trials, and final product validation through the company’s regulatory and quality efforts. Dr. Colantonio plays a critical role in the development of professional partnerships with leading healthcare institutions, and key opinion leaders in the fields of anesthesia, interventional pain management, and infection prevention services with specific emphasis upon the reduction of healthcare acquired conditions (HACs). "There is a very bright future ahead. We are in a unique position to have a significant impact upon improving outcomes for patients by tackling healthcare acquired complications head on, and from multiple solution angles. Exciting and revolutionary changes have been waiting to happen in healthcare, and Fortitude is bringing that wait to an end." Dr. Colantonio stated.
"Anthony’s clinical expertise and entrepreneurial vision is a vital asset to the creation of our life science division". Mr. Parilla stated.
Mr. Parilla added, “As we build our life science division, shareholders will soon recognize the unique opportunity that has been created. The strategic plan now being deployed will aggressively move the Fortitude Group Inc. into a strong position within the life science medical device market. Dr. Colantonio will be working closely with the head of the life science division Chris Cuzzola. The Fortitude Group will be providing more in-depth news on the growth of this Division in the very near future.”
About:
Fortitude Group Inc. develops practical solutions for healthcare with direct holdings, subsidiaries and or joint ventures. The Company’s service-product portfolio includes premium FDA approved medical devices and advanced technologies engineered to prevent the risk associated healthcare acquired conditions and improve clinical outcomes.
Safe Harbor:
This press release contains forward-looking statements. Such forward-looking statements are subject to a number of risks, assumptions and uncertainties that could cause the Company's actual results to differ materially from those projected in such statements. Forward-looking statements speak only as of the date made and are not guarantees of future performance. We undertake no obligation to publicly revise any forward-looking statements.
Contact
Sterling Capitol Investor Relations
Kent Thomas
Phone – (631) 824-7661
FRTD - News out - Erie, PA., January 28, 2013 – Fortitude Group Inc., Today introduces Anthony J. Colantonio, MD Chief Medical Innovation Officer of the Life Science Division.
Fortitude Group Inc., (Ticker Symbol FRTD) CEO Thomas Parilla is pleased to announce Anthony J. Colantonio, MD accepted the position of Chief Medical Innovation Officer of the Life Science Division.
Dr. Colantonio completed fellowship training in Interventional Pain Medicine at the Oregon Health and Science University, residency training at Duke University in Anesthesiology, and medical and undergraduate education at Georgetown University and is a Diplomat of the American Board of Anesthesiology and the American Academy of Pain Management. Dr. Colantonio is the Director of the Clinic for Specialty Pain Services at Meadville Medical Center, with a clinical focus upon neuromodulation therapy and geriatric care. Dr. Colantonio is a regional key opinion leader for numerous pharmaceutical and medical device companies and a national speaker for Pfizer Pharmaceuticals.
As a clinician-inventor, Colantonio is a tireless advocate for patients and medical providers and has dedicated his entrepreneurial career to identifying critical healthcare problems and solving them with innovative products and services. Anthony holds two utility patents through the USPTO and six patents pending. As the Chief Medical Officer of the Life Science Division, Dr. Colantonio leads the research and development efforts from initial product design to bench-top testing, clinical trials, and final product validation through the company’s regulatory and quality efforts. Dr. Colantonio plays a critical role in the development of professional partnerships with leading healthcare institutions, and key opinion leaders in the fields of anesthesia, interventional pain management, and infection prevention services with specific emphasis upon the reduction of healthcare acquired conditions (HACs). "There is a very bright future ahead. We are in a unique position to have a significant impact upon improving outcomes for patients by tackling healthcare acquired complications head on, and from multiple solution angles. Exciting and revolutionary changes have been waiting to happen in healthcare, and Fortitude is bringing that wait to an end." Dr. Colantonio stated.
"Anthony’s clinical expertise and entrepreneurial vision is a vital asset to the creation of our life science division". Mr. Parilla stated.
Mr. Parilla added, “As we build our life science division, shareholders will soon recognize the unique opportunity that has been created. The strategic plan now being deployed will aggressively move the Fortitude Group Inc. into a strong position within the life science medical device market. Dr. Colantonio will be working closely with the head of the life science division Chris Cuzzola. The Fortitude Group will be providing more in-depth news on the growth of this Division in the very near future.”
About:
Fortitude Group Inc. develops practical solutions for healthcare with direct holdings, subsidiaries and or joint ventures. The Company’s service-product portfolio includes premium FDA approved medical devices and advanced technologies engineered to prevent the risk associated healthcare acquired conditions and improve clinical outcomes.
Safe Harbor:
This press release contains forward-looking statements. Such forward-looking statements are subject to a number of risks, assumptions and uncertainties that could cause the Company's actual results to differ materially from those projected in such statements. Forward-looking statements speak only as of the date made and are not guarantees of future performance. We undertake no obligation to publicly revise any forward-looking statements.
Contact
Sterling Capitol Investor Relations
Kent Thomas
Phone – (631) 824-7661
I agree, transparency is so vital down here in pink land.
$FRTD - Morning Tracker, it appears as if Mr. Parilla is putting together a solid organization that will rock the penny world. These two guys are high caliber !!
Outstanding pick up, great for shareholders. This stock will soon show how undervalued it is, Investors who have been waiting for something positive now without question have something to excite them.
GLTY - GLTA
$FRTD - something big is on the way - I can feel it ! Company released more news today.
Erie, PA., January 25, 2013 – Fortitude Group Inc., (Pink OTC Market: FRTD) Today introduces Christopher J. Cuzzola as President.
Thomas Parilla CEO of Fortitude Group Inc. is pleased to announce that he has resigned from his position as President, and that Christopher J. Cuzzola has agreed to accept the position of President.
Christopher J. Cuzzola received a M.Ed. in Administrative Leadership, Learning Theory, and Design from Edinboro University and a B.A. from Mercyhurst University. Cuzzola brings a history of exceptional performance applying his entrepreneurial skills to the challenging life science medical device industry.
During his career with Pfizer, Chris was a consistent high achiever while earning several top specialty and hospital sales performance awards, including a number one ranking as national sales representative of the year. Cuzzola has extensive training in various disease states including infectious diseases. In addition to family and professional passions, Chris remains dedicated to causes associated with advancing education and research.
“This is truly an exciting time for the Fortitude Group, I am honored to work with a fellow Mercyhurst Alum and feel strongly that my experience will compliment the exceptional efforts of our CEO Thomas Parilla- I have tremendous respect for Tom and consider him to be a man of the highest integrity.” “I believe our C-Suite team shares important values, we are passionate about innovation, and strive to be models of the principles and practices we deliver to our internal and external customers with integrity, respect, and responsibility. Our team has a genuine focus upon our core foundational belief: sustained superior performance.” Cuzzola stated.
Thomas Parilla, CEO of Fortitude Group Inc., commented “Chris is a very accomplished executive who possesses enormous talent and passion for our mission and a highly successful track record; furthermore, his unique ability to connect the science of innovation to marketing and sales strategy in the highly competitive life science industry ensures a bright future for our Life Science Division.” “This is a challenging time in healthcare and with these challenges we see unique opportunities, our vision is to save patient lives.” Chris will build an exceptional team with tremendous clinical experience, meeting the healthcare providers needs in this dynamic market.”
About:
Fortitude Group Inc. develops practical solutions for the healthcare industry. Through its direct holdings, subsidiaries and and/or joint ventures the Fortitude Group Inc. will provide the healthcare market with premium products including innovative medical devices, advanced medical technologies and protocol procedures engineered to prevent the risk of infection in the peri-operative setting and improve clinical healthcare outcomes for patients and providers.
Safe Harbor:
This press release contains forward-looking statements. Such forward-looking statements are subject to a number of risks, assumptions and uncertainties that could cause the Company's actual results to differ materially from those projected in such statements. Forward-looking statements speak only as of the date made and are not guarantees of future performance. We undertake no obligation to publicly revise any forward-looking statements.
Thoughts and prayers for stocksdiva
FRTD - its all coming together now!! - NEWS OUT
Erie, PA., January 25, 2013 – Fortitude Group Inc., (Pink OTC Market: FRTD) Today introduces Christopher J. Cuzzola as President.
Thomas Parilla CEO of Fortitude Group Inc. is pleased to announce that he has resigned from his position as President, and that Christopher J. Cuzzola has agreed to accept the position of President.
Christopher J. Cuzzola received a M.Ed. in Administrative Leadership, Learning Theory, and Design from Edinboro University and a B.A. from Mercyhurst University. Cuzzola brings a history of exceptional performance applying his entrepreneurial skills to the challenging life science medical device industry.
During his career with Pfizer, Chris was a consistent high achiever while earning several top specialty and hospital sales performance awards, including a number one ranking as national sales representative of the year. Cuzzola has extensive training in various disease states including infectious diseases. In addition to family and professional passions, Chris remains dedicated to causes associated with advancing education and research.
“This is truly an exciting time for the Fortitude Group, I am honored to work with a fellow Mercyhurst Alum and feel strongly that my experience will compliment the exceptional efforts of our CEO Thomas Parilla- I have tremendous respect for Tom and consider him to be a man of the highest integrity.” “I believe our C-Suite team shares important values, we are passionate about innovation, and strive to be models of the principles and practices we deliver to our internal and external customers with integrity, respect, and responsibility. Our team has a genuine focus upon our core foundational belief: sustained superior performance.” Cuzzola stated.
Thomas Parilla, CEO of Fortitude Group Inc., commented “Chris is a very accomplished executive who possesses enormous talent and passion for our mission and a highly successful track record; furthermore, his unique ability to connect the science of innovation to marketing and sales strategy in the highly competitive life science industry ensures a bright future for our Life Science Division.” “This is a challenging time in healthcare and with these challenges we see unique opportunities, our vision is to save patient lives.” Chris will build an exceptional team with tremendous clinical experience, meeting the healthcare providers needs in this dynamic market.”
About:
Fortitude Group Inc. develops practical solutions for the healthcare industry. Through its direct holdings, subsidiaries and and/or joint ventures the Fortitude Group Inc. will provide the healthcare market with premium products including innovative medical devices, advanced medical technologies and protocol procedures engineered to prevent the risk of infection in the peri-operative setting and improve clinical healthcare outcomes for patients and providers.
Safe Harbor:
This press release contains forward-looking statements. Such forward-looking statements are subject to a number of risks, assumptions and uncertainties that could cause the Company's actual results to differ materially from those projected in such statements. Forward-looking statements speak only as of the date made and are not guarantees of future performance. We undertake no obligation to publicly revise any forward-looking statements.
Contact: Kent Thomas
Sterling Capitol
Phone – (631) 824-7661
Email - IR-FRTD @ sterlingcapitol.net
From what I have been told, the company will be filing their Q , so pink sheets should be updated early to mid next week with the SS. And the yield sign should be removed.
Mick,FRTD is in no way shape or form similar to the old company.
RNDR was destroyed by Stanton and his crew, and with Birmingham out as of today, nothing is left from those crooks.
Going in a new direction with transparency and integrity. Going to be an outstanding journey over the next couple of months. IMHO
$$$$
Afternoon Mick - FRTD hearing much more in the pipeline to come.
I am exicted about the upside potential. keep your eye on it !
GL
D-man